MOHAMMED ALESKANDARANY, PHD, MSC, MBBS
UK Track Program
UCLan Campus - Preston, UK
Mohammed Aleskandarany, PhD, MSc, MBBS, is an associate professor and senior lecturer in pathology at AUC School of Medicine's UK Track program. Dr. Aleskandarany is on faculty at the University of Central Lancashire (UCLan) in Preston UK, where the program is delivered, and is responsible for planning and teaching Pathology-1 course material to third-semester students.
Dr. Aleskandarany has over two decades of experience in medical education and pathology teaching to undergraduate and postgraduate medical and nursing students, where he oversaw the design and delivery of the pathology curriculum. His time in Egypt included leadership memberships of several academic and faculty committees, including the Curriculum and Examinations’ Committee, Students’ Research Committee and Quality Assurance Committee. While at Nottingham University, UK, he taught pathology to MBBS students and pathology tutorial to final year medical students. Recently, he earned PgCert in Medical Education, UClan, UK.
Dr. Aleskandarany earned his doctor of medicine and master’s degrees from Menofyia University, Egypt. After completing his master’s degree in surgical pathology, he pursued his doctorate degree in pathology in the high-esteemed Nottingham Breast Research Group, School of Medicine, University of Nottingham UK, 2007-2011. From 2011 to2014, Dr. Aleskandarany was appointed as an academic clinical consultant pathologist in Menofyia University Hospitals, Egypt. In 2014, he re-joined the Breast Research Group,Nottingham, UK to further his research input. In April 2020, Dr. Aleskandarany joined the University of Central Lancashire as a senior lecturer of pathology.
Dr. Aleskandarany is a pathologist by training and is a cancer expert with main areas of interest being breast pathology. His research interests include multidisciplinary breast cancer translational research to devise novel practice-changing biomarkers of adverse clinical outcome and to refine the currently used prognostic and predictive markers to help improve patients' managements.
Dr. Aleskandarany has published over 85 scientific articles in high-impact peer-reviewed journals and book chapters covering mainly breast cancer prognostic and predictive factors. He has presented his work at international pathology and oncology meetings. He is currently a reviewer and editor to prominent pathology and oncology journals in the field of breast cancer. He is a member of the Egyptian Society of Pathologists, European Society of Pathologists, and The Pathological Society of Great Britain and Ireland.